- Who can participate: Individuals aged 18 to 65 with a diagnosis of asthma may be eligible to participate. Participants should not have any other significant respiratory conditions.
- Study details: Participants will receive either the investigational medication or a placebo. The placebo is an inactive substance that looks like the investigational medication but has no therapeutic effect. Participants will be required to take the study medication as directed and attend regular health assessments.